[Health Technology Assessment Report : Opdivo (ESCC - first-line treatment)

Center for Drug Evaluation
Record ID 32018013828
Chinese (Mandarin)
Details
Project Status: Completed
Year Published: 2024
English language abstract: There is no English language summary available
Publication Type: Not Assigned
MeSH Terms
  • Esophageal Neoplasms
  • Esophageal Squamous Cell Carcinoma
  • Nivolumab
  • Antibodies, Monoclonal, Humanized
Contact
Organisation Name: Center for Drug Evaluation
Contact Address: 3F.,No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. R.O.C.
Contact Name: Li Ying (Grace) Huang
Contact Email: lyhuang277@cde.org.tw
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.